Skip to main content
Clinical Trials/NCT04906148
NCT04906148CompletedNot Applicable

Young Adults' Reactions to Low Nicotine Cigarette Advertising

Abramson Cancer Center at Penn Medicine2 sites in 1 country56 target enrollmentStarted: May 27, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
56
Locations
2
Primary Endpoint
Attention

Study Overview

Brief Summary

Reducing the nicotine content in combustible cigarettes to non-addictive levels has demonstrated promise as a safe and effective public health strategy for decreasing tobacco-caused morbidity and mortality. Little data are available, however, assessing how the marketing of low nicotine content (LNC) cigarettes could dampen their potential population health benefit. This study will examine LNC cigarette advertising content effects on message recall, viewing patterns, product perceptions, and use behaviors. Young adults (N = 340; 170 smokers, 170 non-smokers) will complete a single-session laboratory study using a 2 x 2 between-subject design to manipulate advertisement messaging accuracy (true vs. false/misleading) and content (implicit vs. explicit). Findings may be used to guide public health policy decisions related to regulating cigarette nicotine content and marketing.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Other
Masking
Single (Participant)

Eligibility Criteria

Ages
21 Years to 29 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Aged 21-29
  • Able to use a computer or related technology (such as a smartphone or tablet) with reliable internet access and willing to use the device to participate in the research study.
  • Have a valid email address and willing to use email to participate in the research study. Participants without an existing email account who are willing to create one for study purposes are eligible to participate.
  • Additional inclusion criteria vary by smoking status.

Exclusion Criteria

  • Currently enrolled in a cessation program
  • Report consuming ≥ 25 alcohol-containing drinks per week
  • Report a history or current psychiatric diagnosis or severe medical condition
  • Are color-blind or have another visual impairment (e.g., partial blindness, uncorrected cataract)
  • Self-report being pregnant and/or lactating
  • Are diagnosed with or test positive for COVID-
  • Participants who report having traveled to a high-risk area in the past 2 weeks or who have been in close contact with someone confirmed or being evaluated for COVID-19 will be placed on a waitlist. Waitlisted participants will be asked to self-isolate for 14 days after exposure (even without symptoms) and will be re-screened for eligibility post self-isolation.
  • Additional, general reasons for exclusion include:
  • Significant non-compliance with protocol and/or study design as determined by the Principal Investigator (PI) at any point throughout the study.
  • Past, current, anticipated, or pending enrollment in another research program over the study period that could potentially impact study data as determined by the PI.
  • Any medical condition, illness, disorder, adverse event (AE), or concomitant medication that could compromise participant safety or significantly impact study performance as determined by the PI. Subjects may be deemed ineligible for any of the aforementioned reasons at any point throughout the study, as well as during the initial telephone screen.

Outcomes

Primary Outcomes

Attention

Time Frame: Day 0

Attention to areas of interest defined within the advertisement (e.g., cigarettes, Surgeon General's warning) will be captured with eye tracking software. Attention measures will be assessed in milliseconds using measures of latency (time to first view of specific regions) and dwell time (amount of time spent on regions of interest) obtained from eye-tracking equipment.

Perceived health risks

Time Frame: Day 0

Participants will complete a 13-item measure2 asking them to indicate on a 7-point Likert scale (1 = "very low risk", 7 = "very high risk") their risk of developing 11 health conditions (i.e., lung cancer, heart disease, stroke, high blood pressure, diabetes, asthma, liver disease, emphysema, respiratory infections, other cancers, and addiction) after using regular or the advertised cigarettes, as well as two additional items asking them to evaluate overall risks of the cigarettes for themselves and for others.

Recall

Time Frame: Day 0

Recall will be captured using forced and open items. Multiple-choice format forced items will assess recognition of specific content (e.g., "How much less nicotine is in the advertised cigarettes?") vs. bogus content, scored dichotomously (i.e., correct vs. incorrect). Participants will type answers to open item questions assessing general content (e.g. "What was the overall message of the ad you saw?").

Risk beliefs

Time Frame: Day 0

Risk beliefs will be assessed using individual items and a summary score from a previously validated 8-item scale. Items are rated on a 5-point Likert scale (1 = "definitely untrue", 5 = "definitely true") and will ask participants to compare the advertised cigarettes to "regular" cigarettes on the following statements: a) "are lower in nicotine", b) "are lower in tar", c) "are less addictive", d) "are less likely to cause cancer", e) "have fewer chemicals", f) "are healthier", g) "make smoking safer", h) "help people quit smoking."

Secondary Outcomes

  • Attitudes(Day 0)
  • Purchasing behavior(Day 0)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Andrew Strasser

Professor

Abramson Cancer Center at Penn Medicine

Study Sites (2)

Loading locations...

Similar Trials